Table 4.

Distribution of 241Thr/Thr, 241Thr/Met, and 241Met/Met genotypes and frequencies of the Thr and Met alleles in patients with triple-negative breast cancer and controls

XRCC3 Thr241Met	TNBC patients (n = 70)		Controls (n = 70)		OR (95 % CI)a	p b
	Number	(%)	Number	(%)
241Thr/Thr	19	27	15	21	1.00 Ref
241Thr/Met	35	49	35	50	0.78 (0.34–1.79)	0.718
241Met/Met	16	23	20	29	0.63 (0.24–1.62)	0.475
241Thr	73	52	65	46	1.00 Ref
241Met	67	48	75	54	0.79 (0.49–1.27)	0.402

^aCrude odds ratio (OR), 95 % CI = confidence interval at 95 %

^bChi square